A significant advance in cancer research is occurring with the use of VHH fragments to re-engage damaged p53. This vital tumor suppressor protein is frequently disabled in several forms of malignancies, resulting https://bookmarkick.com/story22000295/mini-antibodies-revive-tumor-suppressor-p53-a-potential-approach-for-malignant-treatment